A new German survey finds that people who use cannabis mainly for relaxation or pleasure tend to consume it more often and alone, while those motivated by socializing use it less frequently and in group settings. These patterns offer useful insight for clinicians assessing individual use behavior, though the study’s cross-sectional design and narrow sample of wine-drinking adults limit broader conclusions.

As cannabis legalization expands in Europe and beyond, clinicians face growing demand to differentiate between use patterns that are stable and socially integrated and those that may signal escalation risk. Understanding why people use cannabis, not just how much, is essential for nuanced clinical conversations. Germany’s April 2024 partial legalization makes its adult population an especially timely setting for examining motivational profiles, yet until now most research on cannabis motives has been conducted with U.S. college students. This study begins to fill that gap, offering a European adult perspective on the motivational architecture underlying different consumption behaviors.

Cannabis use among adults is shaped by a complex interplay of motivations that range from personal relaxation and hedonic pleasure to social facilitation and conversational enhancement. This cross-sectional survey, conducted among German wine-drinking adults aged 20 to 60 who also use cannabis, draws on the validated Marijuana Motives Measure to identify motivational factors and then maps those factors onto two practical dimensions of behavior: how frequently individuals consume cannabis and the social contexts in which they do so. The study is grounded in casual leisure theory, a sociological framework that treats pleasurable, immediately rewarding activities as a distinct category of leisure behavior, and in motivational models of substance use developed by Cox and Klinger and later refined by Cooper.

The key finding is a clean motivational split. Individuals driven by self-focused motives, primarily relaxation and hedonic pleasure, tend to use cannabis more frequently and in solitary or small private settings, often at home alone or with one other person. Those driven by other-focused motives, chiefly sociable conversation and social enhancement, tend to use cannabis less frequently and in group social settings. The study extends earlier U.S. findings to European adults and introduces sociodemographic variables such as education, occupation, and generational cohort into the analysis. However, the cross-sectional design means these are associations only, and the dual-selection criterion of wine drinkers who also use cannabis makes generalization to the broader cannabis-using population difficult. The authors themselves note that longitudinal and experimental follow-up is needed to understand whether motivations drive behavior or behavior shapes reported motivations.

What I appreciate about this study is its insistence on treating cannabis use as a leisure behavior with intelligible motivational structure rather than defaulting to a pathology-first lens. The self-focused versus other-focused distinction maps onto what I observe every day in practice: some patients use cannabis as a private wind-down ritual, while others incorporate it into social gatherings much as they would wine or beer. This framing is genuinely useful. That said, the restriction to wine drinkers is peculiar and limits what we can actually conclude for patients who do not fit that profile, and the lack of reported sample size or detailed analytic methods makes it hard to judge the robustness of the associations.

In my own practice, I routinely ask patients not just how often they use cannabis but why they reach for it and in what setting. Someone who uses cannabis nightly alone to manage insomnia is in a very different clinical conversation than someone who shares a joint at a weekend gathering. The motivational framework this study describes tracks with that approach and reinforces my belief that motivation-aware screening yields more useful clinical data than frequency counts alone.

For clinicians, this study sits early in the research arc connecting motivational psychology to cannabis consumption patterns in adult populations. Most prior work on cannabis motives has used U.S. college student samples, where social enhancement motives dominate and solitary use is relatively uncommon. Extending the Marijuana Motives Measure to a European adult population with broader sociodemographic representation is a meaningful step, but the findings remain descriptive and hypothesis-generating. They do not yet support screening tools, risk stratification, or intervention design because the causal direction of the motivation-behavior link is unknown and the sample selection is idiosyncratic.

From a pharmacological standpoint, the observation that self-focused users consume more frequently and privately deserves clinical attention because higher-frequency solitary use is one of the behavioral markers that prior literature has associated with tolerance development and cannabis use disorder risk. This does not mean that relaxation-motivated users are necessarily at higher risk, but it does mean clinicians should probe further when patients describe a pattern of daily, solitary cannabis use motivated by personal hedonic goals. A concrete, actionable step: when a patient reports daily home-based cannabis use, ask explicitly whether they are seeking relaxation, sleep, mood regulation, or something else, and use that answer to guide conversations about whether the current pattern is serving them well or beginning to feel compulsive.